Pay in 4 interest-free payments of $8.75 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
GSK2118436 is sufficient to reduce S6P phosphorylation in A375
Smiles: COC1=CC2=C(NC3=CC(Br)=C(O)C=C3)N=CN=C2C=C1OC
Mice treated with GSK2110183 at 10
These data suggest that direct inhibition of the oncogenic CBFβ-SMMHC fusion protein may be an effective therapeutic approach for inv(16) AML
WHI-P154 - CAS# 211555-04-3 Catalog No.:M6563-2 GSK2118436 is sufficient to reduceWHI P154, CAS No. 211555 04 3, is a JAK3 inhibitor with IC50 = 1. 8 microM. WHI P154 displays no activity at JAK1 or JAK2. WHI P154 also Inhibits STAT1 activation, iNOS expression and NO production in macrophages in vitro . Also inhibits other common kinases including EGFR (IC50 = 4 nM), Src, Abl, VEGFR, MAPK and PI 3 K and induces apoptosis in human glioblastoma cell lines (IC50 = 158 microM). Product information CAS Number: 211555 04 3 Molecular
US$ 40.00
US$ 32.00
US$ 22.00
US$ 26.00
US$ 23.00
US$ 13500.00
US$ 67.50
US$ 65.00
US$ 21.00
US$ 40.00
US$ 4500.00
US$ 18000.00
US$ 169.99
US$ 600.00
US$ 56.00
US$ 59.00